FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.400
-0.035 (-8.00%)
At close: Mar 9, 2026, 4:00 PM EDT
0.425
+0.025 (6.30%)
After-hours: Mar 9, 2026, 7:59 PM EDT
FibroBiologics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 27 | 15 | 70 | - | - | - | |
| Market Cap Growth | -41.26% | -78.68% | - | - | - | - | |
| Enterprise Value | 25 | 17 | 64 | - | - | - | |
| Last Close Price | 0.43 | 0.22 | 2.00 | - | - | - | |
| PB Ratio | 4.70 | 2.43 | 25.66 | - | - | - | |
| P/TBV Ratio | 4.41 | 2.43 | 25.66 | - | - | - | |
| Debt / Equity Ratio | 0.39 | 0.39 | 3.86 | 1.39 | -1.88 | -1.18 | |
| Net Debt / Equity Ratio | -0.40 | -0.40 | -1.25 | -5.92 | -1.32 | -0.87 | |
| Net Debt / EBITDA Ratio | 0.15 | 0.15 | 0.25 | 0.84 | - | - | |
| Net Debt / FCF Ratio | 0.15 | 0.15 | 0.28 | 1.08 | -1.29 | -0.79 | |
| Quick Ratio | 2.78 | 2.78 | 1.10 | 1.00 | 0.32 | 0.23 | |
| Current Ratio | 3.61 | 3.61 | 1.12 | 1.00 | 0.37 | 0.27 | |
| Return on Equity (ROE) | -419.44% | -419.44% | -559.73% | - | - | - | |
| Return on Assets (ROA) | -79.85% | -79.85% | -60.75% | -66.75% | -105.51% | - | |
| Return on Capital Employed (ROCE) | -211.80% | -211.80% | -369.40% | -337.00% | 198.60% | 122.30% | |
| Earnings Yield | -68.74% | -124.64% | -15.90% | - | - | - | |
| FCF Yield | -61.40% | -111.34% | -17.22% | - | - | - | |
| Buyback Yield / Dilution | -35.85% | -35.85% | -16.45% | - | -222.64% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.